Next 10 |
home / stock / txg / txg articles
On Thursday, Cathie Wood-led Ark Invest made a significant move by selling shares of Coinbase Global Inc (NASDAQ:COIN), despite the stock’s p...
SAN DIEGO, March 14, 2024 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP is investigating 10x Genomics, Inc. (NASDAQ:TXG) ("10x Genomics" or the "Compa...
On Wednesday, Cathie Wood-led Ark Invest made a significant move by selling over $17 million worth of Coinbase Global Inc (NASDAQ:COIN) shares. Thi...
On Wednesday, Cathie Wood-led Ark Invest made a significant move by selling over $6 million worth of Coinbase Global Inc (NASDAQ:COIN) shares, amid...
In a significant move on Tuesday, Cathie Wood-led Ark Invest made headlines by purchasing shares of Roku Inc (NASDAQ:ROKU) worth more than $25 mill...
In a notable move on Thursday, Cathie Wood-led Ark Invest adjusted its portfolio by selling shares of Coinbase Global Inc (NASDAQ:COIN) following t...
In a significant move on Monday, Cathie Wood-led Ark Invest made headlines with its substantial investment in Pinterest Inc (NYSE:PINS), purchasing...
In a move that caught the attention of investors, Cathie Wood-led Ark Invest offloaded over $2.8 million worth of Nvidia (NASDAQ:NVDA) shares on We...
On Monday, NanoString Technologies Inc (NASDAQ:NSTG) voluntarily initiated a Chapter 11 restructuring proceeding in the United States Ban...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
-0.68% Change Percent:
10x Genomics Inc. Company Name:
TXG Stock Symbol:
NYSE Market:
A look at the top 10 most actives in the United States Akanda Corp. (AKAN) rose 52.9% to $0.1422 on volume of 108,274,564 shares CytomX Therapeutics Inc. (CTMX) rose 71.8% to $2.8 on volume of 31,588,176 shares Getaround Inc. (GETR) rose 35.9% to $0.2754 on volume of 26,693,135 shares P...
2024-05-01 06:00:03 ET Luke Sergott from Barclays issued a price target of $36.00 for TXG on 2024-05-01 05:08:00. The adjusted price target was set to $36.00. At the time of the announcement, TXG was trading at $29.28. The overall price target consensus is at $47.50 with...
10x Genomics Reports First Quarter 2024 Financial Results PR Newswire PLEASANTON, Calif. , April 30, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the first quarter end...